After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...
Researchers used an AI-driven approach to identify adalimumab as a potential life-saving treatment for idiopathic ...
In this report, we described both Castleman's disease and lymphoma coexisting in one patient with SIADH. Case presentation: A 70-year-old Chinese woman with a history of diabetes mellitus and ...
Researchers have used AI to find adalimumab effective for iMCD, highlighting the potential of machine learning in discovering ...
EUSA already markets two oncology drugs and is seeking to build its presence in the rare disease market with Sylvant, which has been approved in the US since 2014 to treat multicentric Castleman ...